These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4981305)

  • 1. Hydergine for treatment of symptoms of cerebrovascular insufficiency.
    Triboletti F; Ferri H
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):609-20. PubMed ID: 4981305
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydergine in the treatment of cerebral vascular insufficiency symptoms].
    Triboletti F; Ferri H
    Hospital (Rio J); 1970 May; 77(5):1727-39. PubMed ID: 5311608
    [No Abstract]   [Full Text] [Related]  

  • 5. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rheocencephalographic changes in cerebral vascular diseases in the aged treated with the association of Raubasine and ergot alkaloids].
    Pasoli CA; Mansoldo G
    Minerva Cardioangiol; 1970 Apr; 18(4):267-71. PubMed ID: 5423416
    [No Abstract]   [Full Text] [Related]  

  • 7. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 8. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of clinical studies with ergots in gerontology.
    Venn RD
    Adv Biochem Psychopharmacol; 1980; 23():363-77. PubMed ID: 7395623
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
    Demichelis Genesio MA; Sanz MC
    Angiology; 1981 Oct; 32(10):717-28. PubMed ID: 7034593
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new stimulating agent of cerebrovascular circulation].
    Moreau P
    Nouv Presse Med; 1975 Oct; 4(33):2401-2. PubMed ID: 1105410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 14. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebrovascular insufficiency in the aged: therapeutic action of piribedil. Controlled clinical study].
    De Nicola P
    Minerva Med; 1976 May; 67(26):1736-9. PubMed ID: 778672
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can psychiatric disorders on the aged be influenced by affecting the cerebral circulation?].
    Lambert PA; Bouchardy M
    Sem Ther; 1968 Dec; 44(10):654-5. PubMed ID: 5706292
    [No Abstract]   [Full Text] [Related]  

  • 18. [A double-blind comparison of a sulfurated mucopolysaccharide and placebo in the treatment of elderly patients with cerebrovascular insufficiency].
    Astengo F; Fontana L; Balestreri R
    Clin Ter; 1987 Feb; 120(3):219-26. PubMed ID: 2461828
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 20. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.